Columbia University Medical Center- New York Presbyterian Dept of Oncology — New York, New York

Columbia University Medical Center- New York Presbyterian Dept of Oncology is a clinical research site located in New York, New York, United States 10032.

Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.

Columbia University Medical Center- New York Presbyterian Dept of Oncology has participated in 2 clinical trials.

Therapeutic areas: Medulloblastoma, c-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBM.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in New York

Browse all research sites in New York · View every site in New York

• Celiac Disease Center at Columbia University
• Mt Sinai Hospital - Dept of Dermatology
• Columbia University Medical Cenrer/NYPH
• #1008, Columbia University
• Columbia University - Site 840-125
• Columbia University/New York State Psychiatric Institute
• Columbia University, 710 W 168th St, NI 551, ,
• The New York VA Medical Center, New York University
• State University of New York College of Optometry Clinical Vision Research Center
• Columbia University/Health Science Division
• St. Luke's Hospital, Department of Surgery
• Columbia University Medical Center Eastside

Sponsor Feasibility Report

Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Columbia University Medical Center- New York Presbyterian Dept of Oncology?

Columbia University Medical Center- New York Presbyterian Dept of Oncology has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Columbia University Medical Center- New York Presbyterian Dept of Oncology conducted?

Columbia University Medical Center- New York Presbyterian Dept of Oncology has 2 clinical trials on record. Their work covers Medulloblastoma, c-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBM.

Is Columbia University Medical Center- New York Presbyterian Dept of Oncology accredited by Crixeo Clinical Trials?

Columbia University Medical Center- New York Presbyterian Dept of Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Columbia University Medical Center- New York Presbyterian Dept of Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.